Penumbra (MEX:PEN) Common Stock : MXN1 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Penumbra Common Stock?

Penumbra's quarterly common stock increased from Jun. 2024 (MXN1 Mil) to Sep. 2024 (MXN1 Mil) and increased from Sep. 2024 (MXN1 Mil) to Dec. 2024 (MXN1 Mil).

Penumbra's annual common stock declined from Dec. 2022 (MXN1 Mil) to Dec. 2023 (MXN1 Mil) but then increased from Dec. 2023 (MXN1 Mil) to Dec. 2024 (MXN1 Mil).

Penumbra Common Stock Historical Data

The historical data trend for Penumbra's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Common Stock Chart

Penumbra Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.72

0.76

0.74

0.66

0.79

Penumbra Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															0.66	0.65	0.71	0.75	0.79

Penumbra Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Penumbra Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (MEX:PEN) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

PEN:USA

Address

One Penumbra Place, Alameda, CA, USA, 94502

Website

https://www.penumbrainc.com

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.